Anttinen H, Ryhänen L, Puistola U, Arranto A, Oikarinen A
Gastroenterology. 1984 Mar;86(3):532-9.
Several attempts have been made to develop antifibrotic drugs for human use, but their success has been limited. The present data suggest that peroral zinc treatment has a direct and selective inhibitory effect on carbon tetrachloride-induced collagen accumulation in rat liver. Zinc did not normalize the carbon tetrachloride-induced increases in either liver relative weight, liver total protein content, fat accumulation, or the standard liver function tests, but it did efficiently inhibit liver collagen accumulation. It also reduced skin and liver collagen content and urinary hydroxyproline excretion in normal growing animals, indicating that the inhibition is not limited to the fibroproliferative inflammation associated with carbon tetrachloride injury. Neither inhibition of polysomal protein synthesis nor increased degradation of mature collagen fibers was found to play any major role in the effect of zinc. Instead, a plausible mechanism is inhibition of proline hydroxylation.
人们已多次尝试研发供人类使用的抗纤维化药物,但成效有限。目前的数据表明,口服锌治疗对四氯化碳诱导的大鼠肝脏胶原蛋白积累具有直接且选择性的抑制作用。锌并不能使四氯化碳诱导的肝脏相对重量、肝脏总蛋白含量、脂肪积累或标准肝功能测试恢复正常,但它确实能有效抑制肝脏胶原蛋白的积累。在正常生长的动物中,锌还降低了皮肤和肝脏的胶原蛋白含量以及尿羟脯氨酸排泄,这表明这种抑制作用并不局限于与四氯化碳损伤相关的纤维增生性炎症。未发现多聚核糖体蛋白合成的抑制或成熟胶原纤维降解的增加在锌的作用中起任何主要作用。相反,一个合理的机制是抑制脯氨酸羟化。